Regulatory mechanism of osteoclast activation

被引:26
作者
Nakamura, I [1 ]
Rodan, GA
Duong, LT
机构
[1] Univ Tokyo, Dept Orthopaed Surg, Fac Med, Tokyo, Japan
[2] Yugawara Kosei Nenkin Hosp, Dept Rheumatol, Kanagawa 2590314, Japan
[3] Merck Res Labs, Dept Bone Biol & Osteoporosis, West Point, PA USA
来源
JOURNAL OF ELECTRON MICROSCOPY | 2003年 / 52卷 / 06期
关键词
osteoclast; alpha(v)beta(3) integrin; c-Cbl; c-Src; Pyk2; p130(Cas);
D O I
10.1093/jmicro/52.6.527
中图分类号
TH742 [显微镜];
学科分类号
摘要
Osteoclasts are multinucleated, terminally differentiated cells which play an essential role in bone resorption. Osteoclasts exhibit high expression of the alpha(v)beta(3) integrin, which binds to a variety of extracellular matrix proteins, including vitronectin, osteopontin and bone sialoprotein. RGD (Aug-Gly-Asp)-containing peptides, RGD-mimetics and blocking antibodies to alpha(v)beta(3) integrin were shown to inhibit bone resorption in vitro and in vivo, suggesting that this integrin plays an important role in regulating osteoclast function. A number of signalling molecules were found to be involved in the 03 integrin-dependent signalling pathway, including c-Src, Pyk2 and p130(Cas). Both Pyk2 and p130(Cas) localize to the sealing zone of actively resorbing osteoclasts, suggesting their role in linking the adhesion of osteoclasts to the bone matrix, to cytoskeletal organization, and to the polarization and activation of these cells for bone resorption. in this article, we review the regulatory mechanism of osteoclast activation.
引用
收藏
页码:527 / 533
页数:7
相关论文
共 55 条
[1]   IMMUNOFLUORESCENT EVIDENCE FOR THE ABUNDANCE OF FOCAL ADHESION KINASE IN THE HUMAN AND AVIAN OSTEOCLASTS AND ITS DOWN-REGULATION BY CALCITONIN [J].
BERRY, V ;
RATHOD, H ;
PULMAN, LB ;
DATTA, HK .
JOURNAL OF ENDOCRINOLOGY, 1994, 141 (02) :R11-R15
[2]   REQUIREMENT OF PP60C-SRC EXPRESSION FOR OSTEOCLASTS TO FORM RUFFLED BORDERS AND RESORB BONE IN MICE [J].
BOYCE, BF ;
YONEDA, T ;
LOWE, C ;
SORIANO, P ;
MUNDY, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1622-1627
[3]  
CHAMBERS TJ, 1986, BONE MINER, V1, P127
[4]   INTEGRINS AND SIGNAL-TRANSDUCTION PATHWAYS - THE ROAD TAKEN [J].
CLARK, EA ;
BRUGGE, JS .
SCIENCE, 1995, 268 (5208) :233-239
[5]  
CLOVER J, 1992, J CELL SCI, V103, P267
[6]   Antibody to beta(3) integrin inhibits osteoclast-mediated bone resorption in the thyroparathyroidectomized rat [J].
Crippes, BA ;
Engleman, VW ;
Settle, SL ;
Delarco, J ;
Ornberg, RL ;
Helfrich, MH ;
Horton, MA ;
Nickols, GA .
ENDOCRINOLOGY, 1996, 137 (03) :918-924
[7]   THE OSTEOCLAST FUNCTIONAL ANTIGEN, IMPLICATED IN THE REGULATION OF BONE-RESORPTION, IS BIOCHEMICALLY RELATED TO THE VITRONECTIN RECEPTOR [J].
DAVIES, J ;
WARWICK, J ;
TOTTY, N ;
PHILP, R ;
HELFRICH, M ;
HORTON, M .
JOURNAL OF CELL BIOLOGY, 1989, 109 (04) :1817-1826
[8]   PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of αvβ3 integrin, and phosphorylated by Src kinase [J].
Duong, LT ;
Lakkakorpi, PT ;
Nakamura, I ;
Machwate, M ;
Nagy, RM ;
Rodan, GA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) :881-892
[9]   A peptidomimetic antagonist of the alpha(v)beta(3) integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo [J].
Engelman, VW ;
Nickols, GA ;
Ross, FP ;
Horton, MA ;
Griggs, DW ;
Settle, SL ;
Ruminski, PG ;
Teitelbaum, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2284-2292
[10]   INHIBITION OF OSTEOCLASTIC BONE-RESORPTION INVIVO BY ECHISTATIN, AN ARGINYL-GLYCYL-ASPARTYL (RGD)-CONTAINING PROTEIN [J].
FISHER, JE ;
CAULFIELD, MP ;
SATO, M ;
QUARTUCCIO, HA ;
GOULD, RJ ;
GARSKY, VM ;
RODAN, GA ;
ROSENBLATT, M .
ENDOCRINOLOGY, 1993, 132 (03) :1411-1413